Show simple item record

dc.contributor.authorPatinha, D
dc.contributor.authorCarvalho, C
dc.contributor.authorPersson, P
dc.contributor.authorPihl, L
dc.contributor.authorFasching, A
dc.contributor.authorFriederich‐Persson, M
dc.contributor.authorO'Neill, J
dc.contributor.authorPalm, F
dc.date.accessioned2020-09-01T10:39:41Z
dc.date.issued2020-08-28
dc.description.abstractReduced Na+ intake reduces the partial pressure of oxygen (PO2) in the renal cortex. Upon reduced Na+ intake, reabsorption along the nephron is adjusted with activation of the renin‐angiotensin‐aldosterone system (RAAS). Thus, we studied the effect of reduced Na+ intake on renal oxygen homeostasis and function in rats, and the impact of intrarenal angiotensin II AT1 receptor blockade using candesartan and mineralocorticoid receptor blockade using canrenoic acid potassium salt (CAP). Male Sprague‐Dawley rats were fed standard rat chow containing normal (0.25%) and low (0.025%) Na+ for two weeks. Animals were anesthetized (thiobutabarbital 120 mg kg−1) and surgically prepared for kidney oxygen metabolism and function studies before and after acute intrarenal arterial infusion of candesartan (4.2 μg kg−1) or the intravenous infusion of CAP (20 mg kg−1). Baseline mean arterial pressure and renal blood flow were similar in both dietary groups. Fractional Na+ excretion and cortical oxygen tension were lower, and renal oxygen consumption was higher in low Na+ groups. Neither candesartan nor CAP impacted upon arterial pressure. Renal blood flow increased in both groups after candesartan as well as cortical oxygen tension, on low Na+ group. Fractional Na+ excretion was increased and oxygen consumption reduced on low Na+ group after CAP. These results suggest that blockade of angiotensin II AT1 receptors have a major impact upon oxygen delivery during normal and low Na+, while aldosterone receptors mainly affect oxygen metabolism following two weeks of low Na+ diet.en_GB
dc.description.sponsorshipSwedish Research Councilen_GB
dc.description.sponsorshipSwedish Diabetes Foundationen_GB
dc.description.sponsorshipSwedish Heart-Lung Foundationen_GB
dc.description.sponsorshipFamily Ernfors Funden_GB
dc.description.sponsorshipBritish Heart Foundationen_GB
dc.description.sponsorshipEuropean Union FP7en_GB
dc.identifier.citationPublished online 28 August 2020en_GB
dc.identifier.doi10.1113/jp280481
dc.identifier.grantnumberFS/14/2/30630en_GB
dc.identifier.grantnumberPG/15/68/31717en_GB
dc.identifier.grantnumber612280en_GB
dc.identifier.urihttp://hdl.handle.net/10871/122673
dc.language.isoenen_GB
dc.publisherWiley / Physiological Societyen_GB
dc.rights.embargoreasonUnder embargo until 28 August 2021 in compliance with publisher policyen_GB
dc.rights© 2020 Wiley. All rights reserveden_GB
dc.subjectaldosteroneen_GB
dc.subjectangiotensin IIen_GB
dc.subjecthypoxiaen_GB
dc.subjectkidneyen_GB
dc.subjectlow Na+en_GB
dc.subjectoxygen consumptionen_GB
dc.titleDeterminants of renal oxygen metabolism during low Na + diet: effect of angiotensin II AT 1 and aldosterone receptor blockadeen_GB
dc.typeArticleen_GB
dc.date.available2020-09-01T10:39:41Z
dc.identifier.issn0022-3751
exeter.article-numberJP280481en_GB
dc.descriptionThis is the author accepted manuscript. The final version is available from Wiley via the DOI in this recorden_GB
dc.descriptionData Availability Statement: The data that supports the findings of this study are available in the supplementary material of this articleen_GB
dc.identifier.journalJournal of Physiologyen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2020-08-26
rioxxterms.versionAMen_GB
rioxxterms.licenseref.startdate2020-08-26
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-09-01T10:35:03Z
refterms.versionFCDAM
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record